2021
DOI: 10.1016/j.toxicon.2020.11.490
|View full text |Cite
|
Sign up to set email alerts
|

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles